Liver cells binding with high insulin doses at 37 C

Insulin signaling in liver cells is a well-studied area, with prior research showing that hepatocytes respond to insulin through receptor-mediated processes. However, the specific mechanisms of insulin binding and degradation remain unclear in certain experimental conditions. Earlier studies have established that insulin receptors on hepatocytes facilitate internalization and degradation of the hormone. Yet, the dynamics of these processes under physiological conditions have not been fully resolved. Some research suggests that insulin degradation occurs primarily at the cell surface, but recent findings indicate intracellular accumulation may also occur. The role of pharmacological insulin concentrations in receptor saturation is not fully understood. Limited data exists on how long-term exposure affects insulin binding and degradation rates. This uncertainty has driven investigations into the time course of these processes. Understanding these dynamics is essential for refining models of insulin action in metabolic disorders.

This study aimed to investigate insulin binding and degradation in isolated rat hepatocytes under controlled physiological conditions. The researchers sought to determine how insulin interacts with hepatocyte receptors at varying concentrations and time points. A specific focus was placed on the kinetics of insulin binding and degradation at 37°C. The study also aimed to explore whether intracellular accumulation of insulin occurs at high doses. The researchers were motivated by the need to clarify the mechanisms of insulin degradation and internalization. They wanted to assess whether degradation rates correlate with insulin concentration. The study also aimed to test the effects of pharmacological concentrations on receptor saturation. Understanding these processes could provide insights into insulin resistance and metabolic regulation.

The study used isolated rat hepatocytes incubated with various insulin doses under physiological conditions. The cells were maintained at 37°C in a Krebs improved Ringer III solution containing glucose, glutamate, pyruvate, and fumarate. The researchers measured insulin binding and degradation rates at 15 and 75 minutes. They used radiolabeled insulin to track binding and degradation. The team tested the effects of degradation inhibitors like N-ethylmaleimide and tetracaine hydrochloride. They also used Triton and dodecyl sulphate to solubilize cells and assess insulin recovery. Insulin accumulation was evaluated using Sephadex G 50 superfine filtration. The study included trypsin digestion of receptors to assess binding specificity.

Steady-state insulin binding was achieved within 15 minutes at low insulin doses (0.05–66 ng/tube). Receptor-mediated degradation (Kap) was measured at 0.0479 min-1 at 15 minutes. Degradation rates correlated with low insulin doses, with the slope matching Kap. At pharmacological concentrations (5,000 and 50,000 ng/tube), intracellular insulin accumulation was observed within 15 minutes. This accumulation was dose and time dependent, reaching at least 53% at 75 minutes. Acid filtration showed that accumulated insulin was not extracellular. Solubilization with Triton or dodecyl sulphate confirmed complete insulin recovery after binding. Degradation inhibitors increased intracellular accumulation. Trypsin digestion of receptors reduced degradation and altered binding patterns.

The study suggests that insulin binding reaches a steady state within 15 minutes at low doses. Receptor-mediated degradation occurs at a consistent rate, with Kap values reflecting this process. Intracellular accumulation of insulin is dose and time dependent at high concentrations. The velocity of internalization exceeds degradation at these levels. Degradation inhibitors confirm that accumulation occurs when degradation is blocked. Trypsin digestion alters binding and degradation, suggesting receptor involvement. The findings indicate that intracellular accumulation is a distinct process from degradation. These results provide insights into insulin dynamics in hepatocytes under physiological conditions.